Lotrel News
Sector Snap: Pharmacy Benefit Managers - Forbes
... Lotrel between the time it received final approval from the Food and Drug Administration and the following day when a judge stopped further shipments. ...
Sector Snap: Pharmacy Benefit Managers - Houston Chronicle
... Lotrel between the time it received final approval from the Food and Drug Administration and the following day when a judge stopped further shipments. ...
Novartis To Axe 2500 Jobs Amid Restructuring; To Record $450 Mln ... - RTT News
Adding to the woes, generic drugs are taking sales from the heart treatment Lotrel and anti-fungal Lamisil. For the recently concluded third-quarter, ...
Novartis to Cut 2500 Jobs After Setbacks With Drugs (Update5) - Bloomberg
Generic drugs are taking sales from the heart treatment Lotrel and anti-fungal Lamisil. ``In general, now is not a good time in big pharma,'' Denise ...
Novartis to cut 2500 jobs worldwide by 2010 - USA Today
Growth in the US will be hurt by the loss of sales from bowel drug Zelnorm and generic competition for the company's Lamisil, Lotrel, Famvir and Trileptal ...
Novartis axes 2500 in new cost-cutting drive - Times Online
Competition from generic medicines threatens products including the heart treatment Lotrel and anti-fungal Lamisil. Denise Anderson, analyst at Landsbanki ...
Novartis to implement additional job cuts: Vasella to WSJ - Medical Marketing and Media
And generic competition caught up Lamisil, Lotrel and Famivir. A top pipeline prospect, type 2 diabetes drug Galvus, was delayed at the FDA.
Teva Announces Approval of Generic Trileptal ® Tablets - Business Wire (press release)
... including that relating to the generic versions of Allegra® Neurontin®, Lotrel® and Famvir®, the effects of competition on our innovative products, ...
Novartis planning four new cancer drugs: Oncology president says - Medical Marketing and Media
And generic competition caught up to other top-sellers Lamisil, Lotrel and Famivir. Meanwhile, type 2 diabetes drug Galvus, was delayed at the FDA. ...
Initiation of Enrollment in Pivotal Phase III Clinical Study of ... - American Digital Networks (press release)
... including that relating to the generic versions of Allegra(R), Neurontin(R), Lotrel(R), and Famvir(R), the effects of competition on our innovative ...
Lotrel RSS Feed